Cysteinyl-leukotriene levels in intracerebral hemorrhage: An edema-promoting factor?

Cerebrovascular Diseases

Volumn 8, Issue 6, 1998, Pages 318-326

  Winking, Michael ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Intracerebral hemorrhage; Leukotrienes; Perifocal edema; Stereotactic aspiration

Indexed keywords

ALTEPLASE; PEPTIDOLEUKOTRIENE; PLASMIN;

ADULT; AGED; ANIMAL CELL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CELL; BRAIN HEMORRHAGE; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; EDEMA; HUMAN; METABOLITE; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL ANALYSIS; STEREOTAXIC SURGERY; URINALYSIS;

ANIMALS; BRAIN; BRAIN CHEMISTRY; BRAIN EDEMA; CELLS, CULTURED; CEREBRAL HEMORRHAGE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CREATININE; CYSTEINE; FEMALE; HEMATOMA; HUMANS; LEUKOTRIENES; MALE; MIDDLE AGED; PLASMIN; RATS; RATS, WISTAR;

EID: 0031720705     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000015874     Document Type: Article

References (39)

1. Baskaya MK, Hu Y, Donaldson D, Maley M, Rao AM, Prasad MR, Dempsey RJ: Protective effect of the 5-lipoxygenase inhibitor AA-861 on cerebral edema after transient ischemia. J Neurosurg 1996;85:112-116.
2. 4 receptors in isolated brain capillaries. Adv Prostaglandin Thromboxane Leukot Res 1987; 17:508-511.
3. Bradford M: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
4. 4 binding sites in guinea-pig uterus and lung preparations. J Pharmacol Exp Ther 1985;232: 80-87.
5. Dahlen SE, Hedqvist P, Hammarström S, Samuelsson B: Leukotrienes are potent constrictors of human bronchi. Nature 1989;288: 484-486.
6. Dahlen SE, Bjork J, Hedqvist P, Arfors KE, Hammarström D, Lindgren JA, Samuelson B: Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: In vivo effects with relevance to the acute inflammatory response. Proc Natl Acad Sci USA 1981;78:3887-3891.
7. del Zoppo GJ, Yu JQ, Copeland BR, Thomas WS, Schneiderman J, Morrissey JH: Tissue factor localization in non-human primate cerebral tissue. Thromb Haemost 1992;68:642-647.
8. Drake TA, Morrissey JH, Edgington TS: Selective cellular expression of tissue factor in human tissues: Implication for disorders of hemostasis and thrombosis. Am J Pathol 1989; 134:1087-1097.
9. Edeelston M, de la Torre JC, Oldstone MBA, Loskutoff DJ, Edgington TS, Mackman N: Astrocytes are the primary source of tissue factor in the murine central nervous system: A role for astrocytes in cerebral hemostasis. J Clin Invest 1993;92:349-358.
10. 4 binding sites are S-alkylglutathione binding sites. Eur J Pharmacol 1989;161:99-101.
11. Kamitani T, Little MH, Ellis EF: Effect of leukotrienes, 12-HETE, histamine, bradykinin, and 5-hydroxytryptamine on in vivo rabbit cerebral arteriolar diameter. J Cereb Blood Flow Metab 1985;5:554-559.
12. Keppler D, Huber M, Bumert T, Guhlmann A: Metabolic inactivation of leukotrienes. JAER 1985;28:307-319.
13. Kiwak KJ, Moskowitz MA, Levine L: Leukotriene production in gerbil brain after ischemic insult, subarachnoid hemorrhage, and concussive injury. J Neurosurg 1985;62:865-869.
14. McKinney M: Blockade of receptor-mediated cyclic GMP formation by hydroxyeicosatetraenoic acid. J Neurochem 1987;49:331-341.
15. Minamisawa H, Terashi A, Katayama Y, Kanda Y, Shimizu J, Shiratori T, Inamura K, Kaseki H, Yoshino Y: Brain eicosanoid levels in spontaneously hypertensive rats after ischemia with reperfusion: Leukotriene C4 as a possible cause of cerebral edema. Stroke 1988;19:372-377.
16. Moskowitz MA, Kiwak KJ, Hekimian K, Levine L: Synthesis of compounds with properties of leukotrienes C4 and D4 in gerbil brains after ischemia and reperfusion. Science 1984; 224:886-889.
17. Nemerson Y: The tissue factor pathway of blood coagulation. Semin Hematol 1992;29: 170-176.
18. Palmer MR, Mathews R, Murphy RC, Hoffer BJ: Leukotriene C elicits a prolonged excitation of cerebellar Purkinje neurons. Neurosci Lett 1980;18:173-180.
19. Palmer MR, Mathews R, Höffer BJ, Murphy RC: Electrophysiological response of cerebellar Purkinje neurons to leukotriene D4 and B4. J Pharmacol Exp Ther 1981;219:91-96.
20. Piper PJ, Samhoun MN: Leukotrienes. Br Med Bull 1987;43:297-311.
21. Paoletti P, Gaetani P, Grignani G, Pacchiarini L, Silvani V, Rodriquez y Baena R: CSF leukotriene following subarachnoid hemorrhage. J Neurosurg 1988;69:488-493.
22. Rosenblum WI: Constricting effect of leukotrienes on cerebral arterioles of mice. Stroke 1985;16:262-263.
23. Samuelsson B, Dahlen SE, Lindgren JA, Rouzer CA, Serhan CN: Leukotrienes and lipoxins: Structures, biosynthesis and biological effects. Science 1987;237:1171-1176.
24. Schalling M, Neu A, Terenius L, Lindgren JA, Miamoto T, Hökfelt T, Samuelsson B: Leukotriene C4 binding sites in the rat central nervous system. Eur J Pharmacol 1986;122:251-257.
25. Scheid W: Lehrbuch der Neurologie. Stuttgart, Thieme, 1983.
26. Schweitzer P, Madamba S, Siggins GR: Arachidonic acid metabolites as mediators of somastatin-induced increase of neuronal M-current. Nature 1990;346:464-467.
27. Sergei A, Keller M, Hertting G: Are cerebral prostanoids of astroglial origin? Studies on the prostanoid forming system in developing rat brain and primary cultures of rat astrocytes. Brain Res 1987;404:113-120.
28. Simmet T, Seregi A, Herting G: Formation of sulphidopeptide-leukotrienes by tissue of spontaneously convulsing gerbils. Neuropharmacology 1987;26:107-110.
29. Simmet T, Luck W, Delank WK, Peskar BA: Formation of cysteinyl-leukotrienes by human brain tissue. Brain Res 1988;456:344-349.
30. Simmet T, Luck W, Winking M, Delank WK, Peskar BA: Identification and characterization of cysteinyl-leukotriene formation in tissue slices from human intracranial tumors: Evidence for their biosynthesis under in vivo conditions. J Neurochem 1990;54:2091-2099.
31. Stephens RW, Pöllänen J, Tapiovaara H, Leung KC, Sims PS, Salonen EM, Ronne E, Behrendt N, Dano K, Vaheri A: Activation of pro-urokinase and plasminogen on human sarcoma cells: A proteolytic system with surfacebound reactants. J Cell Biol 1989;108:1987-1995.
32. 4 and FPL 55712 on human and rat cerebral arteries. Adv Prostaglandin Thromboxane Leukot Res 1983;12:357-364.
33. 14C)butyrate by dissociated cells from rat brain. Am J Physiol 1988;255:C133-C139.
34. 2 on isolated human cerebral arteries. Acta Neurochir 1982;62:177-185.
35. Winking M, Lausberg G, Simmet T: Malignancy dependent formation of cysteinyl-leukotrienes in human brain tumor tissues and its detection in urine; in Piscol K, Klinger M, Brock M (eds): Neurosurgical Standards, Cerebral Aneurysms, Malignant Gliomas. Adv Physiol. Berlin, Springer, 1992, vol 20, pp 334-335.
36. Winking M, Boeker DK, Simmet T: Blood-brain cell contact triggers leukotriene formation in brain cells via thrombin. J Cereb Blood Flow Metab 1995;15:700.
37. Winking M, Heldt RM, Simmet T: Thrombin is the stimulus liable for activation of the cerebral 5-lipoxygenase pathway during blood-brain cell contact. J Cereb Blood Flow Metab 1996;16:737-745.
38. Winking M, Hara H, Jödicke J, Moskowitz M, Böker DK: INOS (nitric oxide synthase) activity in experimental brain tumors. J Neurooncol 1996;30:P89.
39. Winking M, Müller HW, Deinsberger D, Joedicke A, Boeker DK: Levels of immunoreactive cysteinyl-leukotrienes in CSF after subarachnoid hemorrhage correlate with blood flowvelocity in TCD. Acta Neurochir 1997;139: 764-769.